DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

Annual Report & Long-Range Plan Released for the 2017-2018 Fiscal Year
November 1, 2018

The Annual Report & Long-Range Plan for the 2017-2018 Fiscal Year is now available to view online. Continue reading


Fourth Quarterly Performance Report Released for the 2017-2018 Fiscal Year
October 1, 2018

The Quarterly Performance Report for the fourth quarter of the 2017-2018 fiscal year is now available online. Continue reading